HCmed Innovations is a company focused on the development of drug-device combination products for inhalation therapy. It develops and manufactures portable vibrating mesh nebulizers that offer a mature customization platform. This technology enables efficient and reliable nebulization of different types of medication, including small molecule synthetics and large molecule biologics, as either solutions, suspensions, or even difficult-to-deliver high viscosity drugs. The newest products include the incorporation of breath actuation and connectivity features to enhance drug delivery and reinforce patience adherence.
投資雷達 查看更多
- 2023-12-05生技股:(漲)合世9.92%、全宇生技-KY4.08%、ABC-KY3.26%;(跌)瑞基9.18%、生華科8.07%、浩泰7.83%
- 2023-12-05法人動態:(買超)太景*-KY767張、台耀746張、永日386張;(賣超)美時2451張、健喬1812張、合一1105張
- 2023-12-04生技股:(漲)合世10%、益安10%、瑞基9.98%;(跌)長佳智能2.96%、福永生技2.51%、台微醫1.82%
- 2023-12-04法人動態:(買超)高端疫苗1793張、太景*-KY1333張、台耀931張;(賣超)松瑞藥2234張、中化509張、博晟生醫303張
- 台股一周TOP 15:11/27-12/01(漲)博晟生醫18.83%、加捷生醫14.39%、松瑞藥11.6%